Everi Hldgs Inc SEC Filings

Form 4 filing overview: BlackSky Technology Inc. (BKSY) disclosed that director James R. Tolonen acquired 1,093 shares of Class A common stock on 30 June 2025. The shares were issued at $0 cost as Mr. Tolonen elected to receive equity rather than cash under the company’s Outside Director Compensation Policy for the quarter ended 30 June 2025. Following the transaction, the director beneficially owns 64,456 shares in total. No derivative securities were reported. The filing represents routine, non-market purchase activity and does not signal any change in corporate strategy or fundamentals.

Wayfair Inc. (symbol W) has filed a Form 144 indicating the intention to sell 180,943 Class A shares through Fidelity Brokerage Services on or about 01 July 2025. The shares carry an aggregate market value of $9.51 million and represent roughly 0.17 % of the company’s 103.66 million shares outstanding.

The shares were originally acquired on 01 January 2002 as “Founder Shares” received as compensation. Within the past three months, related parties named in the filing—Steven K. Conine and the Conine Family Foundation—have already sold 153,963 shares for total gross proceeds of approximately $6.71 million.

• Proposed sale class: Class A
• Broker: Fidelity Brokerage Services LLC, Smithfield RI
• Exchange: NYSE
• Planned sale date: 07/01/2025
• Recent insider sales (last 3 months): ~154 k shares

While the dollar amount is sizeable, the percentage of outstanding shares is small, suggesting limited direct dilution. Nonetheless, the continued disposition of shares by founder-linked entities may influence investor sentiment.

Liquidia Corporation (Nasdaq: LQDA) filed a Form 8-K announcing the appointment of Dana Boyle as Chief Accounting Officer effective July 1, 2025. Boyle, 41, has led the company’s accounting function since January 2021 as SVP-Finance and Controller. Her background includes senior finance roles at Aerami Therapeutics and Aralez Pharmaceuticals, plus public-accounting experience at Deloitte & Touche. She is a licensed CPA (NY) and holds a B.S. in Accounting from Rutgers University.

Compensation package:

• Annual base salary: $425,000
• Target cash bonus: 50 % of base salary
• Equity award: Restricted Stock Units valued at $300,000 on the effective date. Vesting schedule: 25 % on July 11, 2026; remaining 75 % in equal quarterly installments over the following three years, subject to continued employment.

Severance terms: Under the Amended & Restated Executive Severance and Change in Control Plan, Boyle is entitled to up to 12 months of salary continuation, COBRA premium payments, and—if terminated within a change-in-control period—accelerated vesting of 100 % of unvested equity plus target bonus payout.

The filing states that no family relationships or related-party transactions exist. The appointment was not made pursuant to any arrangement with other parties.

Investor take-away: While the event does not directly influence revenue or near-term financials, installing a seasoned CAO may enhance financial reporting quality and internal controls—an incremental positive for governance‐focused investors.

Arini Capital Management Limited and its related entities have filed a Schedule 13G reporting a new passive stake in WW International, Inc. (ticker: WW). The group beneficially owns 639,502 common shares, equal to 6.40 % of WW’s outstanding stock (based on 10 million shares). All voting and dispositive authority is shared; no entity has sole power. Signatories include Arini Capital Management US LLC, Arini Credit Master Fund Ltd, Squarepoint Diversified Partners Fund 7 Ltd, Arini Capital Management Holdings (Jersey) Ltd, and founder/CIO Hamza M. Lemssouguer. The certification states the investment is made for investment purposes only and is not intended to influence control of the issuer.

Everi Holdings Inc. (EVRI) filed a Post-Effective Amendment No. 1 to twelve previously effective Form S-8 registration statements on 1 July 2025. The filing removes from registration all shares of common stock that remain unsold under a range of equity incentive plans dating back to 2006, including the Amended & Restated 2014 Equity Incentive Plan and several legacy Global Cash Access and Multimedia Games plans.

The deregistration is the administrative follow-up to a transformative transaction completed the same day. Under a series of agreements executed on 26 July 2024, Everi and International Game Technology PLC’s (IGT) Gaming & Digital business were simultaneously acquired by Voyager Parent, LLC, an entity owned by funds managed by affiliates of Apollo Global Management. Key closing steps included: (1) IGT transferring its Gaming & Digital assets to a newly formed subsidiary, Spinco; (2) Apollo’s Voyager entities purchasing all Spinco units and the shares of IGT Canada Solutions ULC; and (3) Voyager Merger Sub, Inc. merging with and into Everi, leaving Everi as a wholly owned subsidiary of Apollo-backed Voyager Parent (the “Merger”).

Because Everi will be delisted and its securities deregistered under Section 12(b) of the Exchange Act, the company has terminated all offerings under its outstanding registration statements. Upon effectiveness of this amendment, no additional Everi shares can be issued under the listed employee stock and option plans.

For public investors, the filing signals the formal end of Everi’s status as an SEC-reporting company. For employees and plan participants, any awards not previously settled in connection with the transaction will no longer be serviceable with newly registered shares. No financial results, purchase consideration, or pro-forma figures were disclosed in this document.

Schedule 13D/A Amendment No. 6 for Gabelli Healthcare & Wellness Rx Trust (GRX) Preferred Shares discloses updated ownership information for multiple Gabelli-related entities and individuals.

Aggregate ownership: The Reporting Persons now hold 1,514,000 preferred shares, equal to 45.49 % of the 3,328,500 shares outstanding as of 30 Jun 2025. Key positions include:

• Associated Capital Group (AC): 400,000 shares – 12.02 %
• GAMCO Investors (GBL): 400,000 shares – 12.02 %
• Mario J. Gabelli (individual): 400,000 shares – 12.02 %
• Gabelli Foundation: 314,000 shares – 9.43 %

Recent transactions (26 Jun 2025): Several entities surrendered a total of 1,440,000 preferred shares (Series E & Series G) at $10.00 per share under the Fund’s put right to redeem up to 100 % of its outstanding cumulative preferred stock. The largest single surrender was 830,000 shares by Mario J. Gabelli.

Post-transaction, the group retains a controlling minority of the preferred class, maintaining significant influence over matters requiring preferred-shareholder approval. All reporting persons exercise sole voting and dispositive power over their respective holdings; no shared power is reported. No new legal proceedings or changes in control arrangements were disclosed.

Implications for investors: While the surrender materially reduces absolute ownership, the group’s collective stake remains large at 45 %. The buy-back at par ($10) may signal limited upside in the current preferred valuation and could affect liquidity of the remaining float. However, continued alignment of interests between the Gabelli entities and preferred shareholders persists.

Ford Motor Company (symbol: F) has filed a Form 144 indicating the proposed sale of 30,000 common shares under Rule 144 of the Securities Act of 1933. The shares will be sold through UBS Financial Services, Inc., 11 Madison Ave., New York, NY 10010, with an aggregate market value of $330,000. The approximate sale date disclosed is 07/01/2025, and the shares are to be listed on the NYSE.

The filing shows that the seller originally acquired the shares via three restricted-stock unit (RSU) vesting events on 03/02/2021 (5,424 shares), 03/04/2022 (13,949 shares) and 03/04/2024 (10,627 shares), matching the total of 30,000 shares to be sold. Ford’s total shares outstanding, as referenced in the filing, are 3,905,696,769; therefore, the proposed sale represents roughly 0.0008 % of shares outstanding—an immaterial fraction from a market-capitalization standpoint.

No prior sales were reported during the last three months, and no remarks or 10b5-1 plan adoption dates were disclosed. The filer has affirmed that he or she is not in possession of undisclosed material adverse information.

Investment take-away: While the notice signals insider intent to liquidate equity worth $330,000, the volume is negligible relative to Ford’s float and should not, by itself, influence the valuation or liquidity of Ford shares.

Everi Holdings Inc. (EVRI) has filed Form 25 with the U.S. Securities and Exchange Commission, notifying the SEC and investors that its common stock is being removed from listing and registration on the New York Stock Exchange (NYSE) pursuant to Section 12(b) of the Securities Exchange Act of 1934.

The filing, signed on 1 July 2025 by NYSE representative Tyler Mastronardi, certifies that the Exchange has satisfied all applicable rules under 17 CFR 240.12d2-2(b) for striking the security from listing. No financial statements, earnings data, or explanatory detail regarding the cause of delisting are provided in the document.

• Issuer: Everi Holdings Inc., 7250 S. Tenaya Way, Suite 100, Las Vegas, NV 89113; Tel: (702) 855-3006
• Security affected: Common Stock
• Exchange: New York Stock Exchange LLC
• Action: Removal from listing and/or registration under Rule 12d2-2

The notice indicates either the NYSE or the company (or both) initiated the delisting process in accordance with Exchange and SEC rules, but the form does not specify the underlying reason, effective date, or post-delisting trading venue.

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) filed a Form 8-K reporting two key developments. Under Item 1.01 the Company exercised its contractual right, effective June 27 2025, to terminate the Licensing Agreement with Ocuphire Pharma, Inc. (now Opus Genetics) that had originally been signed on June 16 2021. The filing does not disclose termination fees, financial considerations, or specific reasons for the decision.

Item 7.01 references a press release dated July 1 2025 (Exhibit 99.1) announcing a "strategic portfolio review and pipeline realignment" intended to maximize shareholder value. No operational details, timelines, or updated guidance are included in the 8-K; the press release itself is incorporated by reference but not reproduced in the filing.

The document lists three exhibits—10.1 Termination Agreement, 99.1 Press Release, and 104 iXBRL cover page—and contains no pro-forma financial statements, earnings data, or revised forecasts. As such, investors are informed that Processa has ended one partnered program and is evaluating its development priorities, but the quantitative impact on the Company’s pipeline, cash runway, or future milestones remains undisclosed.